The use of platelet additive solutions to replace the major part of pl
asma as storage medium can improve storage through supply of fuel in p
latelet metabolism. It is important to avoid platelet activation, e.g.
through optimal anticoagulation and gentle procedures at preparation.
Leucodepletion of platelet concentrates (PCs) reduces HLA immunizatio
n and therapeutic refractoriness. Leucofiltration has become common to
obtain leucocyte-depleted PCs, but frequently results in considerable
platelet loss. Attempts at improvements must be validated, e.g. by te
sting post-transfusion increments and function in vivo. The in vitro b
leeding-time test seems to be a valuable tool for the latter purpose.
Bacterial contamination of PCs occur more commonly than so far believe
d; however, severe clinical complications seem to be relatively rare.
Newly available methods for bacterial culture are sufficiently rapid a
nd sensitive to be useful in PC testing. Bacterial decontamination, e.
g, using psoralen-UVA, may be a future possibility for obtaining safer
PCs. (C) 1996 Elsevier Science Ltd.